A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia

NCT06285825 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Cytopenia

Interventions

DRUG: Emapalumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]